Helyn Alvarez, MD
Dermatology · Austin, TXNPI 1770945719
Payments from drug & device makers
Across 181 payments — averaging $34.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Johnson & Johnson$709
- E.r. Squibb & Sons, L.L.C.$599
- Revance Therapeutics, Inc.$541
- Galderma Laboratories, L.p.$318
- Regeneron Healthcare Solutions, Inc.$300
- plus $2K from 21 others
Across 1 payment — averaging $110.59 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$111
What the payments were for
- Food & beverage$5,69492%
- Education$4938%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 54 | $1,357 |
| Johnson & Johnson | 16 | $709 |
| E.r. Squibb & Sons, L.L.C. | 20 | $599 |
| Revance Therapeutics, Inc. | 10 | $541 |
| Galderma Laboratories, L.p. | 7 | $318 |
| Regeneron Healthcare Solutions, Inc. | 9 | $300 |
| Sanofi | 9 | $267 |
| Merz North America, Inc. | 4 | $246 |
| Boehringer Ingelheim | 4 | $204 |
| Amgen | 4 | $193 |
| Incyte Corporation | 5 | $187 |
| Lilly USA, LLC | 5 | $172 |
| Novartis | 7 | $166 |
| Biofrontera Inc. | 2 | $129 |
| Helsinn Therapeutics (U.S.), Inc. | 1 | $122 |
| Pfizer | 2 | $115 |
| UCB, Inc. | 2 | $113 |
| Sun Pharmaceutical Industries Inc. | 3 | $106 |
| Arcutis Biotherapeutics, Inc. | 4 | $79 |
| Mayne Pharma Commercial LLC | 2 | $49 |
| Botanix SB Inc | 2 | $47 |
| Dermavant Sciences, Inc. | 2 | $42 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 2 | $36 |
| Journey Medical Corporation | 2 | $36 |
| Verrica Pharmaceuticals Inc. | 1 | $24 |
| Strata Skin Sciences, Inc. | 1 | $16 |
| Almirall LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,188 in reported general payments places this provider in the 55th percentile of 1,098 dermatology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ketoconazole | 43 | $581 |
| Fluocinonide | 14 | $514 |
| Doxycycline Hyclate | 21 | $296 |
| Triamcinolone Acetonide | 33 | $223 |
| Clobetasol Propionate | 14 | $179 |
| ValacyclovirValacyclovir Hcl | 19 | $166 |
| Mupirocin | 13 | $133 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Austin
- Edward LainAustin$12M
- Janet DuboisAustin$3.5M
- Daniel CarrascoAustin$1.4M
- Dale SchaeferAustin$1M
- Heidi PratherAustin$543K
- Ali ShahbazAustin$413K
- David BushoreAustin$385K
- Blakely RichardsonAustin$279K
- Stephen TyringWebster$14.1M
- Mark LeeSan Antonio$10.9M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.